Spectrofluorimetric determination of amlodipine in human plasma without derivatization

A rapid and sensitive spectrofluorimetric method was developed for the determination of amlodipine (AD), a calcium channel blocker, in the plasma. The type of solvent, the wavelength range, and the range of AD concentration were selected to optimize the experimental conditions. The calibration curve...

Full description

Bibliographic Details
Main Authors: Yucel Kadioglu, Murat Ozturk
Format: Article
Language:English
Published: Universidade de São Paulo 2012-12-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400016
_version_ 1818569330333319168
author Yucel Kadioglu
Murat Ozturk
author_facet Yucel Kadioglu
Murat Ozturk
author_sort Yucel Kadioglu
collection DOAJ
description A rapid and sensitive spectrofluorimetric method was developed for the determination of amlodipine (AD), a calcium channel blocker, in the plasma. The type of solvent, the wavelength range, and the range of AD concentration were selected to optimize the experimental conditions. The calibration curves were linear (r² >0.997) in the concentration range of 0.1-12.5 ppm of AD. The limit of quantitation and limit of detection values for the method for plasma samples were 0.1 ppm and 0.07 ppm, respectively. The precision calculated as the relative standard deviation was less than 3.5%, and the accuracy (relative error) was better than 5.5% (n=6). The method developed in this study can be directly and easily applied for the determination of AD in the plasma without derivatization in plasma.<br>Método espectrofluorometrico rápido e sensível é descrito para a determinação de anlodipina (AD), um bloqueador de canais de cálcio, em amostras de plasma. O tipo de solvente, a faixa de comprimento de onda e a faixa de concentração foram escolhidas a fim de otimizar as condições experimentais. As curvas de calibração foram lineares (r > 0,997) na faixa de concentração de 0,1-12,5 ppm de AD. Os valores LoQ e LoD do método para amostras de plasma foram 0,1 ppm e 0,07 ppm, respectivamente. A precisão calculada como desvio padrão relativo (RSD) foi menor do que 3,5% e a precisão (erro relativo) foi melhor do que 5,5% (n=6). O método desenvolvido neste estudo pode ser fácil e diretamente aplicado para a determinação de AD sem derivatização no plasma.
first_indexed 2024-12-14T06:46:43Z
format Article
id doaj.art-29021b3bf5b648baaf72bc4eea012a34
institution Directory Open Access Journal
issn 1984-8250
2175-9790
language English
last_indexed 2024-12-14T06:46:43Z
publishDate 2012-12-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-29021b3bf5b648baaf72bc4eea012a342022-12-21T23:13:01ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences1984-82502175-97902012-12-01484719725Spectrofluorimetric determination of amlodipine in human plasma without derivatizationYucel KadiogluMurat OzturkA rapid and sensitive spectrofluorimetric method was developed for the determination of amlodipine (AD), a calcium channel blocker, in the plasma. The type of solvent, the wavelength range, and the range of AD concentration were selected to optimize the experimental conditions. The calibration curves were linear (r² >0.997) in the concentration range of 0.1-12.5 ppm of AD. The limit of quantitation and limit of detection values for the method for plasma samples were 0.1 ppm and 0.07 ppm, respectively. The precision calculated as the relative standard deviation was less than 3.5%, and the accuracy (relative error) was better than 5.5% (n=6). The method developed in this study can be directly and easily applied for the determination of AD in the plasma without derivatization in plasma.<br>Método espectrofluorometrico rápido e sensível é descrito para a determinação de anlodipina (AD), um bloqueador de canais de cálcio, em amostras de plasma. O tipo de solvente, a faixa de comprimento de onda e a faixa de concentração foram escolhidas a fim de otimizar as condições experimentais. As curvas de calibração foram lineares (r > 0,997) na faixa de concentração de 0,1-12,5 ppm de AD. Os valores LoQ e LoD do método para amostras de plasma foram 0,1 ppm e 0,07 ppm, respectivamente. A precisão calculada como desvio padrão relativo (RSD) foi menor do que 3,5% e a precisão (erro relativo) foi melhor do que 5,5% (n=6). O método desenvolvido neste estudo pode ser fácil e diretamente aplicado para a determinação de AD sem derivatização no plasma.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400016AnlodipinaMétodo espectrofluorimétricoPlasma humanoAmlodipineSpectrofluorimetric methodHuman plasma
spellingShingle Yucel Kadioglu
Murat Ozturk
Spectrofluorimetric determination of amlodipine in human plasma without derivatization
Brazilian Journal of Pharmaceutical Sciences
Anlodipina
Método espectrofluorimétrico
Plasma humano
Amlodipine
Spectrofluorimetric method
Human plasma
title Spectrofluorimetric determination of amlodipine in human plasma without derivatization
title_full Spectrofluorimetric determination of amlodipine in human plasma without derivatization
title_fullStr Spectrofluorimetric determination of amlodipine in human plasma without derivatization
title_full_unstemmed Spectrofluorimetric determination of amlodipine in human plasma without derivatization
title_short Spectrofluorimetric determination of amlodipine in human plasma without derivatization
title_sort spectrofluorimetric determination of amlodipine in human plasma without derivatization
topic Anlodipina
Método espectrofluorimétrico
Plasma humano
Amlodipine
Spectrofluorimetric method
Human plasma
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400016
work_keys_str_mv AT yucelkadioglu spectrofluorimetricdeterminationofamlodipineinhumanplasmawithoutderivatization
AT muratozturk spectrofluorimetricdeterminationofamlodipineinhumanplasmawithoutderivatization